[HTML][HTML] Systemic radical scavenger treatment of a mouse model of Rett syndrome: merits and limitations of the vitamin E derivative Trolox
OA Janc, MA Hüser, K Dietrich, B Kempkes… - Frontiers in Cellular …, 2016 - frontiersin.org
Rett syndrome (RTT) is a severe neurodevelopmental disorder typically arising from
spontaneous mutations in the X-chromosomal methyl-CpG binding protein 2 (MECP2) gene …
spontaneous mutations in the X-chromosomal methyl-CpG binding protein 2 (MECP2) gene …
Improved analysis of C26: 0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn …
CA Haynes, VR De Jesús - Clinica Chimica Acta, 2012 - Elsevier
BACKGROUND: X-linked adrenoleukodystrophy (X-ALD) is the most common human
peroxisomal disorder, and is caused by mutations in the peroxisomal transmembrane ALD …
peroxisomal disorder, and is caused by mutations in the peroxisomal transmembrane ALD …
Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy
X-linked adrenomyeloneuropathy (AMN) is an inherited neurometabolic disorder caused by
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
malfunction of the ABCD1 gene, characterized by slowly progressing spastic paraplegia …
Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy
N Launay, J Lopez-Erauskin, P Bianchi, S Guha… - Brain, 2024 - academic.oup.com
The peroxisomal disease adrenoleukodystrophy (X-ALD) is caused by loss of the transporter
of very-long-chain fatty acids (VLCFAs), ABCD1. An excess of VLCFAs disrupts essential …
of very-long-chain fatty acids (VLCFAs), ABCD1. An excess of VLCFAs disrupts essential …
Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy
L Granadeiro, VE Zarralanga, R Rosa, F Franquinho… - Brain, 2024 - academic.oup.com
Acyl-CoA binding domain containing 5 (ACBD5) is a critical player in handling very long
chain fatty acids (VLCFA) en route for peroxisomal β-oxidation. Mutations in ACBD5 lead to …
chain fatty acids (VLCFA) en route for peroxisomal β-oxidation. Mutations in ACBD5 lead to …
[HTML][HTML] Improvement of the rett syndrome phenotype in a mecp2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor
K Szczesna, O De La Caridad, P Petazzi… - …, 2014 - nature.com
Rett Syndrome is a neurodevelopmental autism spectrum disorder caused by mutations in
the gene coding for methyl CpG-binding protein (MeCP2). The disease is characterized by …
the gene coding for methyl CpG-binding protein (MeCP2). The disease is characterized by …
7-Ketocholesterol-and 7β-hydroxycholesterol-induced peroxisomal disorders in glial, microglial and neuronal cells: potential role in neurodegeneration: 7 …
Peroxisomopathies are qualitative or quantitative deficiencies in peroxisomes which lead to
increases in the level of very-long-chain fatty acids (VLCFA) and can be associated with …
increases in the level of very-long-chain fatty acids (VLCFA) and can be associated with …
[HTML][HTML] Endocrine manifestations related to inherited metabolic diseases in adults
MC Vantyghem, D Dobbelaere, K Mention… - Orphanet Journal of …, 2012 - Springer
Most inborn errors of metabolism (IEM) are recessive, genetically transmitted diseases and
are classified into 3 main groups according to their mechanisms: cellular intoxication, energy …
are classified into 3 main groups according to their mechanisms: cellular intoxication, energy …
High‐dose biotin restores redox balance, energy and lipid homeostasis, and axonal health in a model of adrenoleukodystrophy
Biotin is an essential cofactor for carboxylases that regulates the energy metabolism.
Recently, high‐dose pharmaceutical‐grade biotin (MD1003) was shown to improve clinical …
Recently, high‐dose pharmaceutical‐grade biotin (MD1003) was shown to improve clinical …
Oxidative stress and mitochondrial dynamics malfunction are linked in P elizaeus‐M erzbacher disease
M Ruiz, M Bégou, N Launay, P Ranea‐Robles… - Brain …, 2018 - Wiley Online Library
Pelizaeus‐Merzbacher disease (PMD) is a fatal hypomyelinating disorder characterized by
early impairment of motor development, nystagmus, choreoathetotic movements, ataxia and …
early impairment of motor development, nystagmus, choreoathetotic movements, ataxia and …